Pillstats
Rx only · Kit

Norethindrone And Ethinyl Estradiol

Brands: Alyacen 1/35 · Alyacen 7/7/7 · Aranelle · Briellyn +9

7 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US20 NDCs
7 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)4124
US makers7 labelers
Packages23
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 13 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.131$0.262$0.393$0.524Dec 2025Apr 2026Jul 2026
$0.405
Latest avg · Jul 22, 2026
-11%
Since Dec 17, 2025
7
Active US suppliers
48%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

13K25K38K51K2025 Q12025 Q22025 Q32025 Q42026 Q1
35K
Rx · 2026 Q1
2.0M
Units dispensed
-21%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it7 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Aurobindo Pharma Limitedunknown6SUPPLYING
Teva Pharmaceuticals USA, Inc.unknown5SUPPLYING
Lupin Pharmaceuticals,Inc.unknown3SUPPLYING
A-S Medication Solutionsunknown3SUPPLYING
Glenmark Pharmaceuticals Inc., USAunknown3SUPPLYING
Proficient Rx LPunknown2SUPPLYING
Naari Pte Limitedunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • May 27, 2026
    RECALLRecall (Class II): Alyacen 7/7/7, Norethindrone and Ethinyl Estradiol Tablets USP, 0.5mg/0.035mg, 0.75mg/0.035mg, 1 mg/0.0.35mg, 3 Blister…

    Failed Impurities/Degradation Specifications: This recall is being initiated due to out-of-specification results total impurities. — Recalling firm: Glenmark Pharmaceuticals Inc., USA — USA Nationwide.

  • Jan 25, 2024
    RECALLRecall (Class III): Nortrel 7/7/7 (norethindrone and ethinyl estradiol tablets USP- triphasic regimen), packaged in cartons, each carton co…

    Discoloration: discolored tablets (shades of blue) mixed in with the white inert remainder tablets. — Recalling firm: Teva Pharmaceuticals USA, Inc — nationwide

  • Jan 25, 2024
    RECALLRecall (Class III): Nortrel (norethindrone and ethinyl estradiol tablets USP) 0.5/35, packaged in cartons, each carton contains 3 blister c…

    Discoloration: discolored tablets (shades of blue) mixed in with the white inert remainder tablets. — Recalling firm: Teva Pharmaceuticals USA, Inc — nationwide

  • Mar 15, 2021
    RECALLRecall (Class II): Balziva 28 Day (norethindrone and ethinyl estradiol tablets USP) 6 Blister Card Dispensers, 28 tablets each, Rx Only, …

    CGMP Deviations: Intermittent exposure to temperature excursion during storage. — Recalling firm: Cardinal Health Inc. — FL, GA, SC

  • Mar 15, 2013
    RECALLRecall (Class III): Balziva(TM) (norethindrone and ethinyl estradiol tablets, USP) 0.15 mg/0.03 mg, 28 day regimen, Rx only, Barr Laborator…

    Failed Impurity/Degradation Specification; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) was detected during impurity testing — Recalling firm: Teva Pharmaceuticals USA, Inc. — Nationwide distribution. No foreign or government accounts.